Ankur Varma
Associate Professor
University of Arkansas for Medical Sciences
faculty
COM | Internal Med Hem-Onc
Research Areas
Is this your profile? Verify and claim your profile
Biography and Research Information
OverviewAI-generated summary
Ankur Varma's research focuses on hematologic malignancies and hematopoietic stem cell transplantation. He has published work on donor-specific anti-HLA antibodies, immune effector cell-associated HLH-like syndrome, and outcomes in patients with myeloproliferative neoplasms undergoing allogeneic stem cell transplant. His publications also address strategies for treating acute myeloid leukemia and myelodysplastic syndrome in older adults, the risk of pulmonary graft-versus-host disease after myeloablative total body irradiation, and hyperhemolysis in sickle cell disease. Varma also investigates HHV-6 associated hyponatremia in cord blood transplant recipients and explores pathogenic mechanisms and therapeutic advances in myelodysplastic syndromes.
Varma holds an h-index of 14 with 86 total publications and 901 total citations. He collaborates with researchers at the University of Arkansas for Medical Sciences, including Mamatha Gaddam, Nishanth Thalambedu, Alan Baltz, and Akash Mukherjee.
Metrics
- h-index: 14
- Publications: 86
- Citations: 901
Selected Publications
- Impact of the CAR-T era on survival in diffuse large B-cell lymphoma: A u.S. population-based cohort study (2025) DOI
- Can the development of drug-induced rash after mogamulizumab administration predict survival in mycosis fungoides/sezary syndrome? a trinetx-based analysis (2025) DOI
- Revaccination status after bone marrow transplant and chimeric antigen receptor T-cell therapy. (2025) DOI
- Navigating Hyperhemolysis in Sickle Cell Disease: Insights from Literature (2025) DOI
- The Effect of Sickle Cell Disease on Seizure-Related Hospitalizations: An Analysis of the Nationwide Inpatient Sample 2021 (2025) DOI
- Epidemiological and clinical trends in common hematological malignancies in Arkansas: Arkansas Central Cancer Registry (ACCR)-based study. (2025) DOI
- Unveiling Myelodysplastic Syndromes: Exploring Pathogenic Mechanisms and Therapeutic Advances (2025) DOI
- Simultaneous Presentation of Relapsed Diffuse Large B-cell Lymphoma and Extrapulmonary Tuberculosis in a Patient With HIV: A Case Report (2025) DOI
- Strategies to Optimize Overutilization of Provider-Ordered Peripheral Blood Smear Review in an University Hospital Setting (2024) DOI
- Impact of Response to Bridging Therapy on Outcomes of CAR-T Therapy in Relapsed/Refractory DLBCL: A Single Center Retrospective Analysis (2024) DOI
- Impact of Social Vulnerability Index and Travel Distance on Access to Chimeric Antigen Receptor T-Cell Therapy (2024) DOI
- Cutaneous Involvement By Peripheral T-Cell Lymphoma: Incidence, Characteristics, Treatment Trends, and Outcomes in the United States (2000-2021) (2024) DOI
- Eculizumab for Hyperhemolysis in Sickle Cell Disease: Key Insights From a Challenging Case (2024) DOI
- Immune Effector Cell-Associated HLH-like Syndrome: A Review of the Literature of an Increasingly Recognized Entity (2023) DOI
Grants & Funding
- MYELOMATCH, Master Screening and Reassessment Protocol (MSRP) for Tier Advancement in the NCI myeloMATCH Clinical Trials NIH/Nat. Cancer Institute - Pass Through: SouthWest Oncology Group Principal Investigator
- MYELOMATCH, Master Screening and Reassessment Protocol (MSRP) for Tier Advancement in the NCI myeloMATCH Clinical Trials NIH/Nat. Cancer Institute - Pass Through: SouthWest Oncology Group Principal Investigator
Collaborators
Researchers in the database who share publications
Similar Researchers
Based on overlapping research topics